GlaxoSmithKline Pharmaceuticals P/E Ratio

Current P/E Ratio

37.34

High Valuation

Very High - High growth expectations or significantly overvalued

GlaxoSmithKline Pharmaceuticals (GLAXO) P/E ratio is 37.34 (High), EPS (TTM) ₹60.11, current price ₹2296.20 on NSE vs historical average P/E of 40.05 (33.3th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see GlaxoSmithKline Pharmaceutical share price chart.

Current Valuation Metrics

P/E Ratio 37.34

Current Price ₹2296.20

EPS (TTM) ₹60.11

Exchange NSE

Valuation Signal

Signal Overvalued

Historical Avg 40.05

Historical Range 17.35 - 55.72

Percentile 33.3%

Sector Context

Sector Average 49.11

Sector Median 28.77

Sector Rank #11 of 193

Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹59.09

Mar 2026 ₹16.40

Sept 2025 ₹15.07

GLAXO P/E Ratio — Valuation Signal & Historical Context

GlaxoSmithKline Pharmaceuticals P/E 37.34 vs historical average 40.05, range 17.35–55.72 — signal: Overvalued. Browse GLAXO cash flow statement for revenue, profit, balance sheet and cash flow data.

Stock appears overvalued with PE of 37.34, suggesting caution for new investments
Trading at discount to sector average PE of 49.11

GlaxoSmithKline Pharmaceuticals P/E Ratio Historical Trend

GLAXO annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 37.34 vs historical average 40.05. Analyse GLAXO shareholder distribution to track promoter, FII and institutional holdings.

GLAXO Historical P/E Ratio — EPS, Year-End Price & Valuation

GlaxoSmithKline Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year	P/E Ratio	EPS (₹)	Year-end Price (₹)	Exchange	Valuation
2025	37.69	59.23	₹2232.10	NSE	High
2024	38.74	50.37	₹1951.55	NSE	High
2023	35.4	37.18	₹1316.30	NSE	High
2022	17.35	100.13	₹1737.15	NSE	Moderate
2021	55.72	28.92	₹1611.50	NSE	High
2020	55.39	29.46	₹1631.85	NSE	High

GLAXO vs Healthcare Peers — P/E Ratio Comparison

GlaxoSmithKline Pharmaceuticals P/E 37.34 vs Healthcare average 49.11, median 28.77 — range 0.97–869.57.

Sector Average

49.11

Sector Median

28.77

Lowest P/E

0.97

Highest P/E

869.57

Companies

193

Company	Symbol	P/E Ratio	Market Cap (₹ Cr)	Valuation
Welcure Drugs & Pharmace…	WELCURE	0.97	₹36	Low
Murae Organisor	MURAE	2.86	₹41	Low
Phaarmasia	PHRMASI	3.13	₹53	Low
Sun Pharma Advanced Rese…	SPARC	4.39	₹7,561	Low
Ind Swift Laboratories	INDSWFTLAB	4.61	₹1,146	Low
Amwill Health Care	AMWILL	6.04	₹65	Low
Mono Pharmacare	MONOPHARMA	6.85	₹20	Low
Medicamen Organics	MEDIORG	6.94	₹28	Low
Brooks Laboratories	BROOKS	7.38	₹166	Low
Shelter Pharma	SHELTER	7.4	₹54	Low